PMID- 25544682
OWN - NLM
STAT- MEDLINE
DCOM- 20150924
LR  - 20150202
IS  - 1878-1780 (Electronic)
IS  - 1262-3636 (Linking)
VI  - 41
IP  - 1
DP  - 2015 Feb
TI  - Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.
PG  - 55-61
LID - S1262-3636(14)00192-X [pii]
LID - 10.1016/j.diabet.2014.11.007 [doi]
AB  - AIM: This analysis estimates the prevalence of type 2 diabetes mellitus (T2DM) in 
      French adults participating in the ObEpi (obesity epidemiology) 2012 survey and 
      also proposes a description of that population, according to comorbidities, 
      treatments and sociodemographic factors related to the disease. METHODS: A 
      self-administered questionnaire was posted to 20,000 households from the Kantar 
      Health panel. In total, 25,714 adults aged>/=18 years and representative of the 
      French population completed the survey between January and March 2012. RESULTS: 
      The prevalence of T2DM was 5.5+/-0.3% (95% CI) in this representative sample of the 
      adult French population. Average age of patients was 65.9 years; 55% were men. 
      Mean body mass index was 29.9kg/m(2) (men: 29.4kg/m(2), women: 30.6 kg/m(2); 
      P<0.01); the prevalence of obesity was 43.1% (men: 39.9%, women: 47.1%; P<0.01). 
      Patient-reported treatments for comorbidities were frequent: high blood pressure, 
      59.1%; dyslipidaemia, 59.9%; myocardial infarction/angina pectoris, 9.7%; 
      revascularization, 7.8%; heart failure, 7.4%; sleep apnoea, 8.3%; and 
      osteoarthritis, 10.7%. With regards to known treatments, 81.4% of patients were 
      taking oral antidiabetic drugs (OADs), and 15.3% were using insulin therapy. 
      Also, 18.8% of diabetic respondents reported financial hardship. CONCLUSION: T2DM 
      remains a disease of major concern: compared with the non-diabetic population, 
      all parameters surveyed showed unfavourable ratings, particularly for women.
CI  - Copyright (c) 2014 Elsevier Masson SAS. All rights reserved.
FAU - Eschwege, E
AU  - Eschwege E
AD  - Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, 
      Epidemiology of diabetes, obesity and chronic renal disease, 94807 Villejuif, 
      France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France. Electronic 
      address: ef.eschwege@wanadoo.fr.
FAU - Basdevant, A
AU  - Basdevant A
AD  - Nutrition Department, hopital Pitie-Salpetriere, AP-HP, 75013 Paris, France; 
      Institute of Cardiology Metabolism and Nutrition, ICAN, 75013 Paris, France.
FAU - Crine, A
AU  - Crine A
AD  - Kantar Health, 92120 Montrouge, France.
FAU - Moisan, C
AU  - Moisan C
AD  - Nutrition Department, hopital Pitie-Salpetriere, AP-HP, 75013 Paris, France.
FAU - Charles, M-A
AU  - Charles MA
AD  - Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, 
      Epidemiology of diabetes, obesity and chronic renal disease, 94807 Villejuif, 
      France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141224
PL  - France
TA  - Diabetes Metab
JT  - Diabetes & metabolism
JID - 9607599
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Comorbidity
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/*epidemiology
MH  - Female
MH  - France/epidemiology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Obesity/*epidemiology
MH  - Prevalence
MH  - Socioeconomic Factors
OTO - NOTNLM
OT  - Comorbidity
OT  - Epidemiology
OT  - Prevalence
OT  - Treatment
OT  - Type 2 diabetes mellitus
EDAT- 2014/12/30 06:00
MHDA- 2015/09/25 06:00
CRDT- 2014/12/30 06:00
PHST- 2014/09/29 00:00 [received]
PHST- 2014/11/18 00:00 [accepted]
PHST- 2014/12/30 06:00 [entrez]
PHST- 2014/12/30 06:00 [pubmed]
PHST- 2015/09/25 06:00 [medline]
AID - S1262-3636(14)00192-X [pii]
AID - 10.1016/j.diabet.2014.11.007 [doi]
PST - ppublish
SO  - Diabetes Metab. 2015 Feb;41(1):55-61. doi: 10.1016/j.diabet.2014.11.007. Epub 
      2014 Dec 24.